Biotech lands Latin American gov’t diabetes contract
Diagnos awarded $4.16M (U.S.) project with Mexico
DIAGNOS INC. has signed a new contract valued at $4.16-million (U.S.). This contract was awarded after the completion of a successful pilot program covering 79,407 patients.
“Based on the execution and results from our 2016 pilot program, ISSSTE (Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado) now has entrusted Diagnos to screen, manage and monitor up to 320,000 patients for the remaining of 2017. Of these patients, all of the 79,407 un-
der Diagnos care, existing patients from 2016 will be rescreened in 2017,” said Andre Larente, president of Diagnos. “After two years of deploying screening projects internationally in more than 15 countries, Diagnos is highly committed to add value to more health programs by providing state-of-the-art technology accessible to people around the world at very competitive cost. Our FLAIRE AI (artificial intelligence) technology platform will be expanded this year to new pathologies discoveries that will benefit the diabetic population and others.”
“Our approach is to monitor ISSSTE’s diabetic population over a three-year period. Patients screened this year will be back for year 2 and year 3 screenings. This recurring revenue for Diagnos ensures the sustainability of our services for the future. Diagnos runs and manages the centred patient oriented programs known for the MIDE diabetes program of ISSSTE,” said Guillermo Moreno, vice-president of Diagnos.
“At ISSSTE we are committed to provide medicare and social security to all of our 13 million affiliates with the best-of-breed technology and innovative health services available worldwide. In a strategic partnership, ISSSTE and Diagnos will continue to work closely to monitor our patients and develop new innovative health solutions,” said Jose Reyes Baeza, director general of ISSSTE.
About About Diagnos Inc.
Diagnos Canadian corporation with a mission to commercialize technologies combining contextual imaging, text and traditional data mining. Diagnos has developed its own artificial intelligence (AI) technologies, CARA and FLAIRE.
We seek Safe Harbor.
Netan Choudhry, Georges Lawrence Hebert, M Andre Larente, P Philip Renaud, Lloyd Mitchell Segal, Michael Singer
(ADK) Shares: 165,727,727